Skip to main content
Top
Published in: World Journal of Surgery 5/2015

01-05-2015 | Original Scientific Report

Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer

Authors: Jai Young Cho, Yoon Jin Lee, Ho-Seong Han, Yoo-Seok Yoon, Jihoon Kim, YoungRok Choi, Hong Kyung Shin, Woohyung Lee

Published in: World Journal of Surgery | Issue 5/2015

Login to get access

Abstract

Background

The initial abdominal computed tomography (CT) scans of patients with colorectal cancer (CRC) sometimes reveal equivocal hepatic lesions. In this study, we evaluated the outcomes of equivocal hepatic lesions found by abdominal CT and the diagnostic accuracy of subsequent liver magnetic resonance imaging (MRI).

Methods

We evaluated data of patients who underwent CRC resection between January 1, 2009 and December 31, 2009. Equivocal hepatic lesions of <1 cm in size on preoperative staging CT scans were included in this study. Gadoxetic acid-enhanced liver MRI was subsequently performed in all patients. Hepatic lesions that grew during the follow-up period (≥3 years) were considered potential metastases.

Results

Overall, 121 equivocal hepatic lesions were detected on preoperative staging CT in 65 out of 494 patients (13.2 %) who underwent colorectal surgery. Based on subsequent MRI, 11 lesions were classified as definitive metastatic lesions and 100 were classified as definitive benign lesions, including simple cysts or hemangiomas. Findings in the other 10 lesions were still inconclusive even after examining CT and MRI. Of the 11 lesions that were classified as metastatic by MRI and were resected, 10 were pathologically confirmed as metastases and one lesion was a pathologically benign nodule. All 100 benign lesions were stable on follow-up imaging and were classified as benign. Of the 10 equivocal lesions, 6 increased in size during the follow up, suggesting they were early metastases, while 4 were stable. The sensitivity and specificity for detecting liver metastases by gadoxetic acid-enhanced MRI of small equivocal hepatic lesions found by CT were 100 % (16/16) and 95.2 % (100/105), respectively, if MRI was equivocal or indicated definite metastasis. The negative predictive value was 100 % (100/100).

Conclusion

Gadoxetic acid-enhanced MRI is a useful diagnostic tool for assessing equivocal hepatic lesions on preoperative CT of CRC patients that allows increased diagnostic accuracy and detection of additional colorectal liver metastasis lesions.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ruers T (2002) Bleichrodt RP Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023–1033CrossRefPubMed Ruers T (2002) Bleichrodt RP Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023–1033CrossRefPubMed
3.
go back to reference Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318 Discussion 318-321CrossRefPubMedCentralPubMed Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318 Discussion 318-321CrossRefPubMedCentralPubMed
4.
go back to reference Sahani DV, Bajwa MA, Andrabi Y et al (2014) Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg 259:861–872CrossRefPubMed Sahani DV, Bajwa MA, Andrabi Y et al (2014) Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma. Ann Surg 259:861–872CrossRefPubMed
5.
6.
go back to reference Kamel IR, Choti MA, Horton KM et al (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227:752–757CrossRefPubMed Kamel IR, Choti MA, Horton KM et al (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227:752–757CrossRefPubMed
7.
go back to reference Bipat S, van Leeuwen MS, Comans EF et al (2005) Colorectal liver metastases: cT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237:123–131CrossRefPubMed Bipat S, van Leeuwen MS, Comans EF et al (2005) Colorectal liver metastases: cT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237:123–131CrossRefPubMed
8.
go back to reference Jang HJ, Lim HK, Lee WJ et al (2002) Small hypoattenuating lesions in the liver on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr 26:718–724CrossRefPubMed Jang HJ, Lim HK, Lee WJ et al (2002) Small hypoattenuating lesions in the liver on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr 26:718–724CrossRefPubMed
9.
go back to reference Schwartz LH, Gandras EJ, Colangelo SM et al (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74CrossRefPubMed Schwartz LH, Gandras EJ, Colangelo SM et al (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74CrossRefPubMed
10.
go back to reference Scharitzer M, Ba-Ssalamah A, Ringl H et al (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187–2196CrossRefPubMed Scharitzer M, Ba-Ssalamah A, Ringl H et al (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187–2196CrossRefPubMed
11.
go back to reference Sica GT, Ji H (2000) Ros PR CT and MR imaging of hepatic metastases AJR. Am J Roentgenol 174:691–698CrossRef Sica GT, Ji H (2000) Ros PR CT and MR imaging of hepatic metastases AJR. Am J Roentgenol 174:691–698CrossRef
12.
go back to reference Eberhardt SC, Choi PH, Bach AM et al (2003) Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med 22:335–343 Quiz 345-336PubMed Eberhardt SC, Choi PH, Bach AM et al (2003) Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med 22:335–343 Quiz 345-336PubMed
14.
go back to reference Kim A, Lee CH, Kim BH et al (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81:3998–4004CrossRefPubMed Kim A, Lee CH, Kim BH et al (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81:3998–4004CrossRefPubMed
15.
go back to reference Hyder O, Dodson RM, Mayo SC et al (2013) Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases Surgery 154:256–265 Hyder O, Dodson RM, Mayo SC et al (2013) Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases Surgery 154:256–265
16.
go back to reference Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072CrossRefPubMed
17.
go back to reference Pawlik TM, Olino K, Gleisner AL et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868CrossRefPubMed Pawlik TM, Olino K, Gleisner AL et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868CrossRefPubMed
18.
go back to reference Fioole B, de Haas RJ, Wicherts DA et al (2008) Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 67:169–176CrossRefPubMed Fioole B, de Haas RJ, Wicherts DA et al (2008) Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 67:169–176CrossRefPubMed
19.
go back to reference van Kessel CS, Buckens CF, van den Bosch MA et al (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19:2805–2813CrossRefPubMedCentralPubMed van Kessel CS, Buckens CF, van den Bosch MA et al (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19:2805–2813CrossRefPubMedCentralPubMed
Metadata
Title
Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer
Authors
Jai Young Cho
Yoon Jin Lee
Ho-Seong Han
Yoo-Seok Yoon
Jihoon Kim
YoungRok Choi
Hong Kyung Shin
Woohyung Lee
Publication date
01-05-2015
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-2944-5

Other articles of this Issue 5/2015

World Journal of Surgery 5/2015 Go to the issue